Jim is the Head of Client Development at Viscadia. His career spans over 20 years of experience driving growth for strategic consulting firms operating in the biopharma and MedTech industries. Jim is passionate about helping his clients make informed investment decisions in disease, asset, and portfolio strategy helping them bring novel therapeutics, medical diagnostics, and devices to patients in need.

Prior to Viscadia, Mr. Martin served as Senior Vice President at Ipsos Healthcare Advisory, where he was responsible for new business growth for North America. Prior to Ipsos, Mr. Martin was Senior Director of Business Development for Putnam Associates, a Biopharma Strategic Consulting company, where he was focused on maximizing client portfolio value and informing investment decisions for disease, asset and portfolio strategy. He holds an MBA from Thunderbird School of Global Management at Arizona State University and a Bachelor of Science in Foreign Service from Georgetown University.
Prior to Viscadia, Jim held senior leadership roles at:
Ipsos Healthcare Advisory
Putnam Associates
Cheskin
Ogilvy Worldwide

BUSINESS EXPERTISE
Disease, Asset, and Portfolio Strategy
Market Opportunity Assessments
Commercial Strategy
Mergers & Acquisitions
Market Research
Forecast Modeling

THERAPEUTIC EXPERTISED
Oncology
Immunology and Inflammation
Rare Disease

EDUCATION
MBA, Thunderbird School of Global Management
Arizona State University
BS in Foreign Service (BSFS)
Georgetown University